positions available now

Tag Archives: Patient Safety

Pharmac reverses controversial brand switch decision

Pharmac has been placed in the spotlight over their decision earlier in the year to fund only one brand of anti-epileptic medication, lamotrigine, instead of the previously funded three lamotrigine brands. Prior to the switch, Medsafe warned Pharmac that the … Continue reading

Posted in Market Access | Tagged , , , , | Comments Off on Pharmac reverses controversial brand switch decision
Copyright © 2014 Commercial Eyes